Expansion of Luspatercept Indication Underscores Evolving Treatment Landscape for Low-Risk MDS
Benjamin Tomlinson, MD, discusses the first-line approval of luspatercept and other ongoing research in low-risk MDS.
Source: onclive.com
International Consensus Classification News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from International Consensus Classification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In International Consensus Classification Today - Breaking & Trending Today
Dr Coombs on Disease Management Strategies in AML
Catherine C. Coombs, MD, discusses strategies for disease classification and management for patients with acute myeloid leukemia.
Source: onclive.com
Updates to MDS Classification Complicate Yet Better Inform Treatment Navigation in MDS
Mikkael A. Sekeres, MD, MS, discusses the influence of therapeutic developments and conflicting classification systems on the management of MDS.
Source: onclive.com
SOC Drugs Provide Strong Foundation For Effective Combinations in Hematologic Malignancies
Catherine C. Coombs, MD, discusses future directions for BTK inhibitors in chronic lymphocytic leukemia and combination therapies in myelofibrosis.
Source: onclive.com
AI Model Differentiates Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy
It can also help identify patients who would benefit from disease-specific therapies.
Source: pharmacytimes.com